Speaker illustration

Doctor Anna Teresinska

Institute of Cardiology, Warsaw (Poland)

The value of cardiac iodine-123-metaiodobenzylguanidine scintigraphy in postinfarction heart failure patients qualified for implantable cardioverter defibrillator in follow up of 2-5 years

Event: ICNC 2019

Topic: Nuclear Imaging

Session: Poster session I

Thumbnail

This platform is supported by

logo Novo Nordisk